Clinical Trial Update: Asia Pacific and Russia Diagnostic Study for EGFR Testing [NA]

View source ↗

Summary

This clinical trial in Asia Pacific and Russia evaluated EGFR mutation testing in advanced non-small cell lung cancer, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: EGFR Mutation Status in aNSCLC Patients | NA | Status: COMPLETED | Results posted: 2016-03-09